๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Augmentation strategies for treatment-resistant depression: a literature review

โœ Scribed by A. F. Carvalho; J. L. Cavalcante; M. S. Castelo; M. C. O. Lima

Book ID
108849055
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
127 KB
Volume
32
Category
Article
ISSN
0269-4727

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Thyroxine Augmentation of Fluoxetine Tre
Thyroxine Augmentation of Fluoxetine Treatment for Resistant Depression in the Elderly: An Open Trial
โœ YORAM BARAK; DANIEL STEIN; JOSEPH LEVINE; ALIZA RING; JACK HADJEZ; AVNER ELIZUR; ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 415 KB ๐Ÿ‘ 2 views

Drug resistant depression is a confounding entity. More so in populations of elderly depressives where addition of lithium or antidepressant combinations are possibly hazardous. We present an open-trial of thyroxine in elderly patients diagnosed as suffering from resistant depression. Methods -Thyro

Olanzapine augmentation of milnacipran f
Olanzapine augmentation of milnacipran for stage 2 treatment-resistant major depression: an open study
โœ Shuken Boku; Takeshi Inoue; Hiroshi Honma; Shigehiro Matsubara; Shin Nakagawa; T ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 88 KB

## Objective Olanzapine augmentation of fluoxetine, a selective serotonin reuptake inhibitor, is an effective augmentation therapy for treatmentโ€resistant depression (TRD). However, studies of olanzapine augmentation of other antidepressants are few. We investigated the efficacy and safety of olanz